zalcitabine has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, R; Klionsky, DJ; Li, C; Liu, J; Tang, D; Zhang, Y | 1 |
| Armand, R; Kintner, J; Lewis, LD; Perez, R; Yeo, TK | 1 |
2 other study(ies) available for zalcitabine and Cancer of Pancreas
| Article | Year |
|---|---|
Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death.
Topics: Animals; Arachidonate 5-Lipoxygenase; Autophagy; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; DNA, Mitochondrial; Ferroptosis; Membrane Proteins; Mice, Inbred NOD; Mice, SCID; Mitochondrial Proteins; Models, Biological; Nucleotidyltransferases; Pancreatic Neoplasms; Proteolysis; Signal Transduction; Stress, Physiological; Transcription Factors; Zalcitabine | 2021 |
Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Deoxycytidine; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Inhibitory Concentration 50; Lactic Acid; Mitochondria; Pancreatic Neoplasms; Reverse Transcriptase Inhibitors; Zalcitabine | 2007 |